Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Treasury Shares (2023 - 2025)

Apyx Medical (APYX) has disclosed Treasury Shares for 3 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares changed 0.08% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Dec 2025, changed 0.08%, and an annual FY2025 reading of $2.1 million, changed 0.08% over the prior year.
  • Treasury Shares was $2.1 million for Q4 2025 at Apyx Medical, roughly flat from $2.1 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.1 million in Q4 2025 and bottomed at $2.1 million in Q4 2023.
  • Average Treasury Shares over 3 years is $2.1 million, with a median of $2.1 million recorded in 2024.
  • The sharpest move saw Treasury Shares increased 3.16% in 2024, then increased 0.08% in 2025.
  • Year by year, Treasury Shares stood at $2.1 million in 2023, then rose by 3.16% to $2.1 million in 2024, then grew by 0.08% to $2.1 million in 2025.
  • Business Quant data shows Treasury Shares for APYX at $2.1 million in Q4 2025, $2.1 million in Q4 2024, and $2.1 million in Q4 2023.